Clinical Trials
5 trialsNCT07493304 2026-03-25
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Not yet recruiting
NCT07005024 2026-02-05
DOAC
University of Vermont
Phase 3 Recruiting
NCT03692065 2025-02-06
API-CAT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed
NCT04462003 2020-07-08
DVT
Beni-Suef University
Phase 3 Unknown